- Home
- AKRO vs ALHC Comparison
AKRO vs ALHC Comparison
Compare AKRO & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKRO | ALHC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.8B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AKRO | ALHC |
|---|---|---|
| Price | $54.65 | $20.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $73.56 | $20.23 |
| AVG Volume (30 Days) | 2.4M | ★ 2.8M |
| Earning Date | 11-07-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,637,156,000.00 |
| Revenue This Year | N/A | $48.51 |
| Revenue Next Year | N/A | $29.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.39 |
| 52 Week Low | $21.34 | $10.18 |
| 52 Week High | $58.40 | $21.06 |
Technical Indicators
Market Signals| Indicator | AKRO | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 71.94 |
| Support Level | $54.30 | $19.89 |
| Resistance Level | $54.70 | $20.80 |
| Average True Range (ATR) | 0.17 | 0.67 |
| MACD | -0.10 | 0.09 |
| Stochastic Oscillator | 71.07 | 86.24 |
Price Performance
Historical ComparisonAbout AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.